Role of the kallikrein-kinin system in diabetic retinopathy
Description: PUBLIC HEALTH RELEVANCE: Diabetes macular edema is a leading cause of vision loss. Recent studies have revealed that an enzyme named plasma kallikrein in increased in the vitreous of people with diabetic retinopathy and contributes impairment to retinal vascular dysfunction via a pathway that is VEGF independent. This grant will perform studies using both knockout animal models and pharmacological approaches to identify the mechanisms of plasma kallikrein's effects on the retina and potential crosstalk with the VEGF pathway.
Funder: National Eye Institute
Funding type: research
Funder scheme: R01
Start date: 2008-09-01
End date: 2018-03-31
Investigator: LLOYD P AIELLO
Institution: JOSLIN DIABETES CENTER
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Funded outputs count: 38
Funder award ID: R01EY019029
OpenAlex ID: G4889415366
